Chakraborty I, Das S K, Dey S K
Department of Physiology, Ralph L Smith Research Center, University of Kansas Medical Center, Kansas City 66160-7338, USA.
J Endocrinol. 1995 Nov;147(2):339-52. doi: 10.1677/joe.0.1470339.
Vascular endothelial growth factor (VEGF) is a mitogen for endothelial cells and an inducer of angiogenesis. VEGF is also known as a vascular permeability factor because it can stimulate vascular permeability. In the rodent, increased uterine vascular permeability occurs at the sites of blastocysts with the onset of the attachment reaction. This is followed by stromal decidualization and angiogenesis. We examined the temporal and spatial expression of VEGF and its receptors, Flk-1 and Flt-1, in the mouse uterus during the peri-implantation period (days 1-8) using Northern and in situ hybridization to assess the involvement of VEGF in the process of implantation. Primarily, a major (approximately 4.2 kb) transcript for VEGF mRNA was detected in uterine poly(A)+ samples, except for the presence of two other minor (approximately 3.7 and 2.5 kb) transcripts in decidual samples. The steady-state levels of these transcripts did not vary much during the peri-implantation period, except for an increase in day-8 decidual samples. Results of in situ hybridization experiments demonstrated accumulation of VEGF mRNA in the luminal epithelium on days 1 and 2. In contrast, stromal cells exhibited a modest level of signals on day 3. On day 4, luminal epithelial cells and those in the subepithelial stromal bed accumulated VEGF mRNA. On days 5-7, a clear cell type-specific accumulation of this mRNA was noted. On day 5 after the initial attachment reaction, luminal epithelial and stromal cells immediately surrounding the blastocyst exhibited accumulation of VEGF mRNA. On days 6-8, the accumulation occurred in cells in the decidual bed at both the mesometrial and antimesometrial poles. The embryo, especially the trophoblast giant cells, also accumulated VEGF mRNA on day 8. The expression of the VEGF receptors, Flk-1 and Flt-1, was also examined. A single transcript (approximately 6.5-7.0 kb) for Flk-1 mRNA and two transcripts (approximately 6.5 and 7.5 kb) for that of Flt-1 were detected in poly(A)+ uterine RNA samples. In situ hybridization studies showed accumulation of Flk-1 mRNA in a subset of cells in the stromal bed on day 4, but not in any uterine cell types on day 1. On days 5-8, cells in both the mesometrial and antimesometrial decidual beds exhibited accumulation of Flk-1 and Flt-1 mRNAs. Lectin binding (Dolichos biflorus agglutinin) was used to identify newly sprouting endothelial cells (angiogenesis), while an antibody to the von Willebrand factor (vWF) was employed to identify endothelial cells in general.(ABSTRACT TRUNCATED AT 400 WORDS)
血管内皮生长因子(VEGF)是一种内皮细胞促分裂原,也是血管生成的诱导剂。VEGF也被称为血管通透性因子,因为它能刺激血管通透性。在啮齿动物中,随着着床反应的开始,子宫血管通透性在囊胚着床部位增加。随后是基质蜕膜化和血管生成。我们使用Northern杂交和原位杂交技术,检测了围植入期(第1 - 8天)小鼠子宫中VEGF及其受体Flk - 1和Flt - 1的时空表达,以评估VEGF在植入过程中的作用。首先,在子宫poly(A)+样本中检测到VEGF mRNA的一个主要转录本(约4.2 kb),蜕膜样本中还存在另外两个较小的转录本(约3.7和2.5 kb)。这些转录本的稳态水平在围植入期变化不大,除了第8天的蜕膜样本有所增加。原位杂交实验结果显示,第1天和第2天VEGF mRNA在腔上皮细胞中积累。相反,第3天基质细胞的信号水平适中。第4天,腔上皮细胞和上皮下基质床中的细胞积累了VEGF mRNA。在第5 - 7天,观察到该mRNA有明显的细胞类型特异性积累。在初始附着反应后的第5天,围绕囊胚的腔上皮和基质细胞显示出VEGF mRNA的积累。在第6 - 8天,积累发生在子宫系膜侧和反子宫系膜侧蜕膜床的细胞中。胚胎,尤其是滋养层巨细胞,在第8天也积累了VEGF mRNA。我们还检测了VEGF受体Flk - 1和Flt - 1的表达。在子宫poly(A)+ RNA样本中检测到Flk - 1 mRNA的一个单一转录本(约6.5 - 7.0 kb)和Flt - 1的两个转录本(约6.5和7.5 kb)。原位杂交研究表明,第4天Flk - 1 mRNA在基质床的一部分细胞中积累,但第1天在任何子宫细胞类型中均未检测到。在第5 - 8天,子宫系膜侧和反子宫系膜侧蜕膜床中的细胞均显示出Flk - 1和Flt - 1 mRNA的积累。使用凝集素结合(双花扁豆凝集素)来识别新发芽的内皮细胞(血管生成),同时使用抗血管性血友病因子(vWF)抗体来识别一般的内皮细胞。(摘要截断于400字)